Parham Academy LLC
European Academy of Biomedical Sciences


Our news & hot issues


ISI Impact factor= 5.49 (Q1)



(Reverse chronological order)

Molecular modelling, molecular dynamics simulations and in vitro evaluation of Berberine as an inhibitor of MAP kinase and PI3K pathway. (2017: Accepted as Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Molecular modelling of berberine derivatives as inhibitors of smoothened receptor using a new drug discovery script for a large numbers of compounds. (2017: Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Is it the right way to use intercalating agents as inhibitors of MAP kinase pathway? A challenging issue using berberine with dual cellular functionality applied in breast cancer cell models. (2017: Poster presentation; Role: presenter), In: "Tumour Microenvironment – Basic Science to Novel Therapies", 15th June 2017, Nottingham, UK.

Molecular modelling and molecular dynamics simulations of a new berberine derivative as a dual RAF inhibitor for treatment of drug resistance acquired in melanoma. (2016: Oral presentation; Role: Presenter), In: "Pharmacology", British Pharmacological Society, 13th December, London, UK. (Abstract)

Tissue regeneration in mammals: Role of Oct4 gene expression in treatment of infectious diseases. (2010: Poster presentation; Role: Presenter) "10th International MEEGID Conference (Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases)", Nov. 2010, Amsterdam, Netherlands (Elsevier).

A new cell line detected in mouse: A novel theory of stem cell applications in tissue regeneration. (2010: Oral presentation; Role: Presenter) "11th Iranian Genetics Congress", Shahid Beheshti University, May. 2010, Tehran.
ASPET annual meeting




Author watson Home 15:42:17 | | | printer friendly | | create pdf of this news item


Our article: Therapeutic miRNAs


 Pharmacological Research




Headlines





Date published: not known
Details

»Measuring the far side of the Galaxy
»3D gene expression blueprint of the fly
»Mechanical systems at the quantum level
»3D texture morphing for camouflage
»A signature event for organoids
»Forests out of balance
»Fevers, TRPV channels, and birth defects
»Newborn brain imaging made easier
»Light- and dark-zone death dynamics
»A radical route from methane to methanol


Date published: not known
Details

»Correction to "A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation" [ERRATUM]
»E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Mice with Colitis [Articles]
The chemokine fractalkine (CX3C chemokine ligand 1; CX3CL1) and its receptor CX3CR1 are involved in ...
»Selective HIF-1 Regulation under Nonhypoxic Conditions by the p42/p44 MAP Kinase Inhibitor PD184161 [Articles]
Hypoxia-inducible factor-1 (HIF-1) is a key gene regulator for cellular adaptation to low oxygen. I ...
»Transforming Growth Factor-{beta}1/Activin Receptor-like Kinase 5-Mediated Cell Migration is Dependent on the Protein Proteinase-Activated Receptor 2 but not on Proteinase-Activated Receptor 2-Stimulated Gq-Calcium Signaling [Articles]
Transforming growth factor-β (TGF-β), serine proteinases such as trypsin, and proteinase- ...
»Prostaglandin E2 Inhibits Histamine-Evoked Ca2+ Release in Human Aortic Smooth Muscle Cells through Hyperactive cAMP Signaling Junctions and Protein Kinase A [Articles]
In human aortic smooth muscle cells, prostaglandin E2 (PGE2) stimulates adenylyl cyclase (AC) and a ...
»A Single Amino Acid Substitution in the Third Transmembrane Region Has Opposite Impacts on the Selectivity of the Parasiticides Fluralaner and Ivermectin for Ligand-Gated Chloride Channels [Articles]
Fluralaner (Bravecto) is a recently marketed isoxazoline ectoparasiticide. This compound potently i ...
»The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity [Accelerated Communication]
Drug interactions are often analyzed in terms of isobolograms. In the isobologram, the line connect ...
»N-Acetyl-L-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to Glutathione [Articles]
N-acetyl-l-cysteine (NAC) exhibits protective properties in brain injury models and has undergone a ...
»The Anthracycline Metabolite Doxorubicinol Abolishes RyR2 Sensitivity to Physiological Changes in Luminal Ca2+ through an Interaction with Calsequestrin [Articles]
The chemotherapeutic anthracycline metabolite doxorubicinol (doxOL) has been shown to interact with ...
»Agonist-Dependent and -Independent {kappa} Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes [Articles]
We reported previously that the selective agonist U50,488H promoted phosphorylation of the mouse o ...


Date published: not known
Details

»A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action
»Clusternomics: Integrative context-dependent clustering for heterogeneous datasets
»The role of glutamate in neuronal ion homeostasis: A case study of spreading depolarization
»Network approaches and applications in biology
»Ten simple rules for writing a response to reviewers
»BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions
»Identifying direct contacts between protein complex subunits from their conditional dependence in proteomics datasets
»Vicus: Exploiting local structures to improve network-based analysis of biological data
»Systematic, network-based characterization of therapeutic target inhibitors
»Network propagation in the cytoscape cyberinfrastructure
»Incorporating networks in a probabilistic graphical model to find drivers for complex human diseases
»Structural host-microbiota interaction networks


Date published: not known
Details


THE FOUNDER and CEO

Parham Jabbarzadeh Kaboli, PhD

Research scientist
in molecular medicine


Expert in:

Cell and molecular Biology
Modelling and drug discovery
Cancer signaling pathways

H-index= 3 (Google Scholar)
i10-index= 3
Overall ISI impact factor= 18.15
Overall citation= 110 (Google Scholar)

Memberships:

The American Society for Pharmacology and Experimental Therapeutics (ASPET)

American Association for Cancer Research (AACR)

European Association for Cancer Research (EACR)

American Association for Advancement of Science (AAAS)



CONTACT INFORMATION


Affiliation:
Department of Biomedical Science,
Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
UPM Serdang 43400,
Selangor, Malaysia

E-Mail: parham@gromacs.net
Telegram: telegram.me/parhamacademy
Featured Publication





View the full list.
Archives

Welcome

Username:

Password:



[ ]







This site is powered by Parham Academy.
This site is powered by Parham Academy.
Render time: 0.0984 sec, 0.0044 of that for queries.